Susan M. Ludeman - Concepedia

Author

Susan M. Ludeman

Duke Medical Center

Also Known As

S M Ludeman, Susan Ludeman, Susan M Ludeman, Susan M. Ludeman, Susan Marie Ludeman

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Duke Medical Center University of Chicago Johns Hopkins University Johns Hopkins Medicine Duke University

About

Susan M. Ludeman is an author at Duke Medical Center specializing in pharmacology, biochemistry, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	361
2	Biochemistry	8	8	351
3	Natural Sciences	7	7	309
4	Engineering	2	2	71
5	Public Health	2	2	151

Susan M. Ludeman

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity Robert W. Storms, Aliana P. Trujillo, James B. Springer, Proceedings of the National Academy of Sciences	1999	534
The Chemistry of the Metabolites of Cyclophosphamide Susan M. Ludeman Current Pharmaceutical Design Medicinal ChemistryMetabolite PrecursorsBioorganic ChemistryHeterocyclicBiochemistry	1999	151
Short-term exposure of human ovarian follicles to cyclophosphamide metabolites seems to promote follicular activation in vitro Yechezkel Lande, Benjamin Fisch, Abraham Tsur, Reproductive BioMedicine Online Hormonal ContraceptiveHuman Ovarian FolliclesOogenesisMedicineGynecology	2016	103
Phosphorus-31 nuclear magnetic resonance spectroscopic observation of the intracellular transformations of oncostatic cyclophosphamide metabolites Victoria L. Boyd, Joan D. Robbins, William Egan, Journal of Medicinal Chemistry	1986	57
Modulation of cyclophosphamide activity by O ? 6 -alkylguanine-DNA alkyltransferase Stewart P. Johnson, Natalia A. Loktionova, M. Eileen Dolan, Cancer Chemotherapy and Pharmacology Bioorganic ChemistryBiochemistryNatural SciencesOligonucleotideMechanism Of Action	1999	55
NMR spectroscopic studies of intermediary metabolites of cyclophosphamide. A comprehensive kinetic analysis of the interconversion of cis- and trans-4-hydroxycyclophosphamide with aldophosphamide and the concomitant partitioning of aldophosphamide between irreversible fragmentation and reversible conjugation pathways Gerald Zon, Susan M. Ludeman, Joan A. Brandt, Journal of Medicinal Chemistry	1984	50
Intraneoplastic polymer-based delivery of cyclophosphamide for intratumoral bioconversion by a replicating oncolytic viral vector. Tomotsugu Ichikawa, William P. Petros, Susan M. Ludeman, PubMed EngineeringProdrug ActivationCell DeathBiomedical EngineeringImmunotherapy	2001	49
Effect of O6-benzylguanine on alkylating agent-induced toxicity and mutagenicity. In Chinese hamster ovary cells expressing wild-type and mutant O6-alkylguanine-DNA alkyltransferases. Yingna Cai, Michael H. Wu, Meng Xu‐Welliver, PubMed Dna DamageCell DeathAgt Repair ProteinToxicological MechanismOvarian Cancer	2000	48
Pharmacodynamic and pharmacokinetic study of chronic low-dose metronomic cyclophosphamide therapy in mice Urban Emmenegger, Yuval Shaked, Shan Man, Molecular Cancer Therapeutics Activated CpaLdm CpaOncologyPharmacological StudyMedicine	2007	48
Synthesis and antitumor activity of cyclophosphamide analogs. 4. Preparation, kinetic studies, and anticancer screening of phenylketophosphamide and similar compounds related to the cyclophosphamide metabolite aldophosphamide Susan M. Ludeman, Victoria L. Boyd, Judith B. Regan, Journal of Medicinal Chemistry	1986	42

Page 1